Farallon Capital Management’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
2023
Q2
$357K Sell
2023
Q1
$509K Sell
2022
Q4
$911K Sell
2022
Q3
$1.76M Hold
2022
Q2
$1.56M Sell
2022
Q1
$2.27M Sell
2021
Q4
$6.28M Buy